The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(3-Cyano-4-hydroxy-5-trifluoromethylbenzoyl)-1,2-dihydro-3H-1,3-benzothiazole ID: ALA4744184
PubChem CID: 68108480
Max Phase: Preclinical
Molecular Formula: C16H9F3N2O2S
Molecular Weight: 350.32
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1cc(C(=O)N2CSc3ccccc32)cc(C(F)(F)F)c1O
Standard InChI: InChI=1S/C16H9F3N2O2S/c17-16(18,19)11-6-9(5-10(7-20)14(11)22)15(23)21-8-24-13-4-2-1-3-12(13)21/h1-6,22H,8H2
Standard InChI Key: ZMYHQWPKHSCITJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
18.3331 -25.0564 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
16.1402 -25.3205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1390 -26.1400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8471 -26.5490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8453 -24.9116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5539 -25.3169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5587 -26.1401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3431 -26.3899 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8231 -25.7211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6002 -27.1656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0569 -27.7761 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4005 -27.3308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6528 -28.1089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4523 -28.2743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9964 -27.6635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7356 -26.8846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9367 -26.7229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7970 -27.8277 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.2750 -26.2700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8119 -25.6579 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7089 -29.0502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1654 -29.6604 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
21.5092 -29.2158 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.9168 -29.8357 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 1 1 0
1 6 1 0
8 10 1 0
10 11 2 0
10 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
15 18 1 0
16 19 1 0
19 20 3 0
14 21 1 0
21 22 1 0
21 23 1 0
21 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 350.32Molecular Weight (Monoisotopic): 350.0337AlogP: 3.99#Rotatable Bonds: 1Polar Surface Area: 64.33Molecular Species: ACIDHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.12CX Basic pKa: ┄CX LogP: 3.46CX LogD: 2.23Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.84Np Likeness Score: -1.47
References 1. Uda J,Kobashi S,Miyata S,Ashizawa N,Matsumoto K,Iwanaga T. (2020) Discovery of Dotinurad (FYU-981), a New Phenol Derivative with Highly Potent Uric Acid Lowering Activity., 11 (10): [PMID:33062187 ] [10.1021/acsmedchemlett.0c00176 ]